+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 3 Actively Recruiting clinical trials

R

Actively Recruiting

This research aims to evaluate food allergies in adults with Irritable Bowel Syndrome IBS by using a skin patch test with 80 different foods and additives. The study investigates whether avoiding foods identified as allergens through this patch test can improve IBS symptoms compared to avoiding foods not identified as allergens. The study is randomized, double-blind, and placebo-controlled, involving a multi-center design to assess the effect of food allergen avoidance on IBS treatment. Participants undergo three office visits over 4 to 5 days for patch testing. Patches with the test foods are applied to the back and removed 48 hours later, after which the skin is assessed for allergic reactions. Those found to have food allergies are randomly assigned to follow one of two diets for 16 weeks a true avoidance diet eliminating allergic foods or a sham diet avoiding foods not identified as allergens. Neither the participants nor the doctors know which diet is assigned during this period. During the study, participants complete questionnaires about their IBS symptoms after the 16-week diet period. The study team monitors symptom changes through an online survey. After completing the diet and questionnaire, participants on the sham diet are informed of their true food allergies and may choose to avoid those foods. The total participation time is about 18 weeks, including screening, patch testing, dietary avoidance, and follow-up questionnaires.

Age: 18Years +All GendersPhase Not Applicable
2 locations
L

Actively Recruiting

Researchers are evaluating the performance of the Gynecare TVT ABBREVO4 Continence System in women undergoing mid-urethral sling surgery to treat Stress Urinary Incontinence SUI. This observational, post-market clinical study focuses on long-term follow-up to assess the systems impact on continence over approximately 5 to 10 years after surgery. Participants undergo surgical treatment for SUI using the Gynecare TVT ABBREVO4 device as part of standard care. There is no additional intervention in the study beyond the usual surgical procedure and clinical care. The study follows participants from the time of surgery through long-term follow-up lasting about 10 years. During the study, participants will be monitored with assessments including the Cough Stress Test CST to evaluate continence status, patient-reported improvement measures, urinary incontinence questionnaires, sexual function questionnaires, and pain rating scales. Follow-up involves regular evaluations through the study completion date to track outcomes and safety over the long term.

Age: 21Years +FEMALE
4 locations
L

Actively Recruiting

This research aims to evaluate the long-term safety and effectiveness of the Neuspera Sacral Neuromodulation SNM System in people with urinary urgency incontinence who have previously participated in earlier phases of the Neuspera SANSUUI study. The system has received FDA approval for patients who have not responded to more conservative treatments or cannot tolerate them. This study fulfills the post-approval requirements to monitor the devices performance over time. Participants in this study have already received the Neuspera SNM System implant during Phase I or Phase II of the prior study. The focus is on observing the devices effects and safety up to 72 months after implantation. No new treatments or placebo groups are involved, as this is a single-arm follow-up study of the approved device. During the study, participants will have regular follow-up visits to assess safety and effectiveness outcomes for up to six years after implantation. Researchers will monitor participants urinary symptoms and any device-related issues over time. The study is designed to collect comprehensive long-term data to better understand the devices ongoing impact and safety in real-world use.

Age: 22Years +All GendersPhase Not Applicable
20 locations